Delivery Order SPE2DB22D2103-SPE2DB25FR9NW
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a Delivery Order valued at $10,567.60 by the Defense Logistics Agency (DLA) for the supply of LYNPARZA 150 mg tablets (120-count units). The contract is a firm fixed-price, non-set-aside award with a completion date of August 21, 2025, and was issued on July 31, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $10,499.34 to AmerisourceBergen Drug Corp for 60 tablets of LYNPARZA 150 mg, a pharmaceutical product for oncology treatment. The contract, awarded on August 19, 2025, with an ultimate completion date of September 10, 2025, carries firm fixed pricing and represents a non-set-aside competitive award. Performance will be executed at the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $21,039.24 by the Defense Logistics Agency on September 17, 2025, for the supply of Lynparza 100 mg tablets (120-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 8, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,567.60 to AmerisourceBergen Drug Corp for the supply of Lynparza 150 mg tablets (120-count units). The contract was awarded on August 12, 2025, with an ultimate completion date of September 3, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $10,519.62 to AmerisourceBergen Drug Corp for 120 tablets of Lynparza 100 mg on August 20, 2025, with an ultimate completion date of September 11, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child order, this delivery falls under a larger contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,543.70 for 60 tablets of Lynparza 100 mg on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a continuation of pharmaceutical supply services under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $10,519.62 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lynparza 100 mg tablets (120-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 30, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,519.62 for 120 tablets of Lynparza 100 mg on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed...
- The Defense Logistics Agency awarded a $10,519.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Lynparza 100 mg, with an ultimate completion date of August 14, 2025. This is a non-set-aside, competitively awarded contract classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a $10,519.62 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for 120 tablets of Lynparza 100 mg. This contract is a non-set-aside competitive award with an ultimate completion date of July 17, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9NWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,499.34 to AmerisourceBergen Drug Corp for 60 tablets of Lynparza 150 mg, a specialty pharmaceutical product used in oncology treatment. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, with fulfillment to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that authorizes the company to supply comprehensive pharmaceutical and medical supplies globally to support military healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency's Medical Supply Chain. The company's federal contracting demonstrates significant capability in fulfilling diverse medical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical devices. This delivery order for Lynparza reflects AmerisourceBergen's ongoing role as a critical supplier to military and federal healthcare systems, supporting the Defense Health Agency, U.S. Coast Guard, and other government entities through its flexible contracting vehicles without set-aside restrictions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 7/24/25 |